Search

everythinglearnresearchcommunity

for

Search:↓

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Kids with early graying hair often have low levels of calcium, ferritin, and vitamin D3.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Erosive pustular dermatosis of the scalp is a rare condition that causes scarring hair loss, mainly in older women, and requires ongoing treatment.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Adalimumab can cause complete hair loss in rare cases.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Both mouse and rat models are effective for testing alopecia areata treatments.

Early diagnosis and a strict gluten-free diet are crucial for children with celiac disease to improve symptoms.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.